Boston Scientific Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2018
Total Assets: $21.00B
Liabilities Breakdown FY2018
Total Liabilities: $12.27B
Asset Breakdown
Total Assets: $21.00B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $146.0M | 0.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $1.17B | 5.6% |
| Property, Plant & Equipment | $1.78B | 8.5% |
| Goodwill | $7.91B | 37.7% |
| Intangible Assets | $6.37B | 30.3% |
| Other Assets | $3.62B | 17.2% |
Liabilities Breakdown
Total Liabilities: $12.27B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $349.0M | 2.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $11.92B | 97.2% |